Evidence map›Paper›PMID 29637002›Full record

ArticleAmerican journal of cancer research2018

MiR-216a exerts tumor-suppressing functions in renal cell carcinoma by targeting TLR4.

Wanhui Wang, Enyang Zhao, Yang Yu, Bo Geng, Wenfu Zhang, Xuedong Li

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Targeting miRNAs in renal cell carcinoma: emerging therapeutic strategies.International journal of clinical oncology · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. A Review of Recent Research on the Role of MicroRNAs in Renal Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wanhui WangDepartment of Urology, The Second Affiliated Hospital of Harbin Medical UniversityHarbin 150086, China.
Enyang ZhaoDepartment of Urology, The Second Affiliated Hospital of Harbin Medical UniversityHarbin 150086, China.
Yang YuDepartment of Urology, The Second Affiliated Hospital of Harbin Medical UniversityHarbin 150086, China.
Bo GengDepartment of Urology, The Second Affiliated Hospital of Harbin Medical UniversityHarbin 150086, China.
Wenfu ZhangDepartment of Urology, The Second Affiliated Hospital of Harbin Medical UniversityHarbin 150086, China.
Xuedong LiDepartment of Urology, The Second Affiliated Hospital of Harbin Medical UniversityHarbin 150086, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MiR-216a, a tumor-related microRNA (miRNA), has been reported to be implicated in the tumorigenesis and progression of diverse types of human malignancies; however, its role in renal cell carcinoma (RCC) remains unclear. This study aimed to explore the biological role of miR-216a in RCC and clarify the potential mechanisms involved. In the present study, miR-216a was found to be significantly down-regulated in both RCC tissues and cell lines. Functional studies demonstrated that enhanced expression of miR-216a suppressed RCC cell proliferation, migration and invasion

Indexed as

miR-216aRenal cell carcinomaTLR4tumor-suppressing

Identifiers

PMID29637002
PMCPMC5883097
OpenAlexW2984180255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.